Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1549 |
Damnacanthal
丹宁卡 |
IL Receptor; Akt; Syk | Angiogenesis; Cytoskeletal Signaling; Immunology/Inflammation; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
Damnacanthal possesses anti-cancer, immunomodulatory, antinociceptive and anti-inflammatory actions, it can treat or prevent hepatocellular carcinoma through its inhibitory effects on the HGF/c-Met axis. |